AU
UK
CA
US
IND
NZ
Last update at 2026-06-05T14:33:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Venture Life Group And 2 Other UK Penny Stocks To Watch Closely
Mon 07 Jul 25, 07:05 AM| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | 0.02M | 1.12M | 0.71M | 0.95M | 3.28M |
| Minority interest | - | - | - | - | - |
| Net income | -0.31400M | 0.92M | 0.52M | 2.40M | 2.37M |
| Selling general administrative | - | - | - | - | 6.35M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 12.19M | 20.15M | 17.66M | 12.96M | 12.85M |
| Reconciled depreciation | 2.81M | 6.64M | 5.38M | 3.70M | 1.99M |
| Ebit | 1.51M | 3.30M | 3.33M | 2.66M | 3.56M |
| Ebitda | 4.32M | 9.95M | 8.71M | 6.36M | 6.17M |
| Depreciation and amortization | 2.81M | 6.64M | 5.38M | 3.70M | 2.62M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 1.51M | 3.29M | 3.33M | 2.66M | 3.56M |
| Other operating expenses | 25.08M | 48.12M | 40.66M | 30.19M | 25.95M |
| Interest expense | 1.50M | 2.18M | 1.52M | 0.51M | 0.33M |
| Tax provision | 0.05M | 0.20M | 0.19M | -1.45600M | 0.91M |
| Interest income | - | 0.01M | 0.00100M | 0.09M | 0.05M |
| Net interest income | -1.49600M | -2.16600M | -1.52100M | -0.42500M | -0.27900M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.05M | 0.20M | 0.19M | -1.45600M | 0.91M |
| Total revenue | 26.59M | 51.41M | 43.98M | 32.76M | 30.08M |
| Total operating expenses | 10.67M | 16.86M | 14.34M | 10.39M | 8.72M |
| Cost of revenue | 14.41M | 31.26M | 26.32M | 19.80M | 17.23M |
| Total other income expense net | -1.49600M | -2.16600M | -2.62000M | -1.71100M | -0.27900M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -0.02700M | 0.92M | 0.52M | 2.40M | 2.37M |
| Net income applicable to common shares | - | - | - | 2.40M | 2.37M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 124.49M | 119.50M | 125.29M | 103.63M | 92.68M |
| Intangible assets | 33.23M | 36.03M | 39.04M | 29.60M | 5.75M |
| Earning assets | - | - | - | - | - |
| Other current assets | 52.86M | 1.63M | - | 12.21M | 7.65M |
| Total liab | 49.08M | 43.24M | 49.63M | 30.47M | 20.57M |
| Total stockholder equity | 75.41M | 76.25M | 75.66M | 73.16M | 72.11M |
| Deferred long term liab | - | - | - | 1.94M | 2.01M |
| Other current liab | 13.84M | 3.27M | 0.89M | 2.40M | 0.43M |
| Common stock | 0.38M | 0.38M | 0.38M | 0.38M | 0.38M |
| Capital stock | 0.38M | 0.38M | 0.38M | 0.38M | 0.38M |
| Retained earnings | 0.04M | 0.21M | -0.71300M | -1.34900M | -3.75100M |
| Other liab | - | - | - | 7.83M | 1.85M |
| Good will | 15.39M | 38.59M | 39.65M | 35.48M | 21.28M |
| Other assets | - | - | - | 2.35M | 2.01M |
| Cash | 3.05M | 5.62M | 5.63M | 5.24M | 42.09M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 19.26M | 29.68M | 16.48M | 10.53M | 10.00M |
| Current deferred revenue | - | 0.27M | - | -2.20900M | - |
| Net debt | 20.81M | 18.77M | 21.21M | 7.49M | -30.91700M |
| Short term debt | 1.66M | 20.34M | 3.87M | 0.62M | 2.46M |
| Short long term debt | 1.34M | 19.30M | 0.00000M | 0.00000M | 1.98M |
| Short long term debt total | 23.86M | 24.39M | 26.85M | 12.73M | 11.18M |
| Other stockholder equity | 65.96M | 65.96M | 75.99M | 74.14M | 75.48M |
| Property plant equipment | - | - | - | 9.74M | 7.02M |
| Total current assets | 71.82M | 32.16M | 34.06M | 26.47M | 58.63M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | 8.09M | 47.09M |
| Short term investments | - | - | - | - | - |
| Net receivables | 10.83M | 16.20M | 16.43M | 12.21M | 7.34M |
| Long term debt | 21.78M | 0.00000M | 19.33M | 8.48M | 4.64M |
| Inventory | 5.08M | 10.33M | 12.00M | 9.02M | 8.89M |
| Accounts payable | 2.73M | 5.80M | 11.72M | 9.72M | 7.11M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 9.03M | 9.70M | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | 0.38M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | - | 36.03M | - | - | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 52.67M | 87.34M | 91.23M | 77.17M | 34.04M |
| Capital lease obligations | 0.73M | 5.09M | 7.52M | 4.25M | 4.56M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -11.29400M | -5.34000M | -11.68800M | -39.17900M | -7.53400M |
| Change to liabilities | - | - | - | -0.90800M | 1.40M |
| Total cashflows from investing activities | -11.29400M | -5.34000M | - | -39.17900M | -7.53400M |
| Net borrowings | 5.70M | -1.02800M | - | 1.99M | 1.23M |
| Total cash from financing activities | 1.78M | -2.80600M | 6.92M | 1.50M | 36.27M |
| Change to operating activities | - | - | - | - | - |
| Net income | 0.02M | 0.92M | 0.71M | 0.95M | 3.28M |
| Change in cash | -1.30300M | -0.00900M | 0.40M | -36.86000M | 31.39M |
| Begin period cash flow | 5.62M | 5.63M | 5.24M | 42.09M | 10.71M |
| End period cash flow | 4.32M | 5.62M | 5.63M | 5.24M | 42.09M |
| Total cash from operating activities | 8.35M | 8.22M | 5.57M | 0.60M | 2.71M |
| Issuance of capital stock | 0.00200M | 0.00000M | 0.22M | 0.00000M | 37.00M |
| Depreciation | 2.81M | 6.64M | 5.38M | 3.70M | 1.99M |
| Other cashflows from investing activities | -1.80600M | -1.58700M | - | - | -5.46500M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -0.35500M | 1.48M | -2.32900M | 0.72M | -3.29400M |
| Change to account receivables | -2.46500M | 0.10M | - | -2.98900M | -1.16100M |
| Sale purchase of stock | - | - | - | - | 37.00M |
| Other cashflows from financing activities | -3.92300M | -2.39000M | 13.43M | 15.12M | 2.71M |
| Change to netincome | - | - | - | -2.32400M | 1.40M |
| Capital expenditures | 0.01000M | 2.41M | 4.21M | 3.26M | 2.07M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -0.07300M | -1.00500M | -1.35700M | -3.17900M | -3.05200M |
| Stock based compensation | 0.23M | 0.23M | 0.07M | 0.20M | 0.41M |
| Other non cash items | 5.37M | 1.44M | 0.76M | 0.42M | 0.28M |
| Free cash flow | 8.34M | 5.81M | 1.36M | -2.66100M | 0.64M |
Sector: Consumer Defensive Industry: Household & Personal Products
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VLG Venture Life Group PLC |
-0.5 0.76% | 65.50 | - | 15.48 | 2.24 | 0.95 | 1.25 | 14.00 |
| ULVR Unilever PLC |
110.50 2.71% | 4188.50 | 19.06 | 15.41 | 1.86 | 6.73 | 2.51 | 11.39 |
| RKT Reckitt Benckiser Group PLC |
84.00 1.88% | 4549.00 | 10.71 | 15.13 | 2.37 | 4.31 | 2.82 | 8.41 |
| PZC PZ Cussons PLC |
2.10 2.46% | 87.40 | - | 9.64 | 0.63 | 1.42 | 0.81 | 7.05 |
| TBTG The Beauty Tech Group PLC |
25.00 7.58% | 355.00 | 54.42 | 10.70 | 2.67 | 598.72 | 3.11 | 14.60 |
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; and Baby Earol, an ear spray for babies under the Earol and EarolSwim brands. It also provides oncology support products, such as Pomi-T for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid-based topical gel, for the prevention and treatment of radiation-induced dermatitis. The company operates in Germany, the Netherlands, France, Sweden, Denmark, Lithuania, rest of Europe, the United States, Canada, Brazil, Ireland, and internationally. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
12 The Courtyard, Bracknell, United Kingdom, RG12 2XB
| Name | Title | Year Born |
|---|---|---|
| Mr. Jeremy Anthony Philip Randall ACA | Co-Founder, CEO & Exec. Director | 1965 |
| Ms. Sharon Mary Daly Collins | Co-Founder, Chief Commercial Officer & Exec. Director | 1975 |
| Mr. Daniel James Wells | CFO & Director | 1987 |
| Mr. Lodovico Gianluca Braguti | Chief Manufacturing Officer & Exec. Director | NA |
| Ben Colman | Director of Corp. Devel. | NA |
| Mr. Domenico Barbaro | Head of Procurement | NA |
| Mr. Giuseppe Gioffrè | Group Financial Controller & Company Sec. | NA |
| Mr. Jeremy Anthony Philip Randall ACA | Co-Founder, CEO & Executive Director | 1964 |
| Mr. Peter Jackson | Chief Digital & Technology Officer | NA |
| Ben Colman | Director of Corporate Development | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...